UK markets open in 2 hours 31 minutes

Moderna, Inc. (MRNA)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
175.93-6.42 (-3.52%)
At close: 04:00PM EST
174.31 -1.62 (-0.92%)
After hours: 07:59PM EST
Full screen
Trade prices are not sourced from all markets
Previous close182.35
Open180.99
Bid175.50 x 800
Ask176.00 x 900
Day's range173.59 - 183.68
52-week range115.03 - 321.30
Volume3,525,387
Avg. volume4,758,662
Market cap67.589B
Beta (5Y monthly)1.73
PE ratio (TTM)6.10
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Zacks

    Should Investors Buy Pfizer (PFE) & Moderna (MRNA) Stock for 2023?

    Much of the social and economic post-pandemic recovery is accredited to Covid-19 vaccine makers Pfizer (PFE) and Moderna (MRNA). Investors may be wondering if these stocks will continue to be strong investments going into 2023.

  • Reuters

    Pfizer, BioNTech countersue Moderna over COVID-19 vaccine patents

    (Reuters) -Pfizer Inc and its German partner, BioNTech SE, fired back at Moderna Inc on Monday in a patent lawsuit over their rival COVID-19 vaccines, seeking dismissal of the lawsuit in Boston federal court and an order that Moderna's patents are invalid and not infringed. Moderna first sued Pfizer in August, accusing the company of violating its rights in three patents related to innovations that Cambridge, Massachusetts-based Moderna said it pioneered before the COVID-19 pandemic. Moderna has also filed a related lawsuit against Pfizer and BioNTech in Germany.

  • Fool.co.uk

    Best British growth stocks to buy for December

    We asked our freelance writers to reveal the top growth shares they’d buy in December, which included a rare double nomination for one stock... The post Best British growth stocks to buy for December appeared first on The Motley Fool UK.